Bcl	O
-	O
2	O
decreases	O
cell	B-Cell
proliferation	O
and	O
promotes	O
accumulation	O
of	O
cells	B-Cell
in	O
S	O
phase	O
without	O
affecting	O
the	O
rate	O
of	O
apoptosis	O
in	O
human	O
ovarian	B-Cell
carcinoma	I-Cell
cells	I-Cell
.	O

OBJECTIVES	O
:	O

The	O
Bcl	O
-	O
2	O
protein	O
is	O
an	O
important	O
regulator	O
of	O
the	O
apoptotic	O
cascade	O
and	O
promotes	O
cell	B-Cell
survival	O
.	O

Bcl	O
-	O
2	O
can	O
also	O
delay	O
entry	O
into	O
the	O
cell	B-Cell
cycle	O
from	O
quiescence	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
used	O
two	O
isogenic	O
human	O
ovarian	B-Cell
carcinoma	I-Cell
cell	I-Cell
lines	I-Cell
,	O
which	O
expressed	O
differential	O
levels	O
of	O
Bcl	O
-	O
2	O
proteins	O
,	O
to	O
demonstrate	O
that	O
Bcl	O
-	O
2	O
may	O
regulate	O
the	O
growth	O
rates	O
of	O
adenocarcinoma	B-Cell
cells	I-Cell
.	O

METHODS	O
:	O

The	O
growth	O
rates	O
of	O
two	O
isogenic	O
ovarian	B-Cell
cancer	I-Cell
cell	I-Cell
lines	I-Cell
were	O
determined	O
by	O
XTT	O
assays	O
and	O
flow	O
cytometry	O
combined	O
with	O
PI	O
staining	O
.	O

Bcl	B-Cell
-	I-Cell
2	I-Cell
-	I-Cell
overexpressing	I-Cell
SKOV3	I-Cell
cells	I-Cell
were	O
modified	O
to	O
express	O
a	O
doxycycline	O
-	O
inducible	O
anti	O
-	O
Bcl	O
-	O
2	O
single	O
-	O
chain	O
antibody	O
and	O
the	O
effects	O
of	O
Bcl	O
-	O
2	O
protein	O
inhibition	O
on	O
cell	B-Cell
proliferation	O
and	O
apoptosis	O
were	O
assessed	O
.	O

RESULTS	O
:	O

We	O
demonstrate	O
that	O
Bcl	O
-	O
2	O
promotes	O
the	O
accumulation	O
of	O
proliferating	O
carcinoma	B-Cell
cells	I-Cell
in	O
S	O
phase	O
.	O

The	O
Bcl	B-Cell
-	I-Cell
2	I-Cell
-	I-Cell
overexpressing	I-Cell
SKOV3	I-Cell
cell	I-Cell
line	I-Cell
proliferates	O
markedly	O
faster	O
and	O
shows	O
delayed	O
progression	O
to	O
G2M	O
phase	O
compared	O
to	O
its	O
low	O
Bcl	B-Cell
-	I-Cell
2	I-Cell
-	I-Cell
expressing	I-Cell
counterpart	I-Cell
SKOV3	I-Cell
.	I-Cell
ip1	I-Cell
cell	I-Cell
line	I-Cell
.	O

Single	O
-	O
chain	O
antibody	O
-	O
mediated	O
inhibition	O
of	O
Bcl	O
-	O
2	O
in	O
SKOV3	B-Cell
cells	I-Cell
was	O
associated	O
with	O
increased	O
growth	O
rates	O
and	O
more	O
rapid	O
cell	B-Cell
cycle	O
progression	O
.	O

Treatment	O
with	O
cisplatin	O
resulted	O
in	O
more	O
cells	B-Cell
accumulating	O
in	O
S	O
phase	O
in	O
Bcl	B-Cell
-	I-Cell
2	I-Cell
-	I-Cell
overexpressing	I-Cell
SKOV3	I-Cell
cells	I-Cell
,	O
while	O
the	O
inhibition	O
of	O
Bcl	O
-	O
2	O
abolished	O
delayed	O
entry	O
into	O
G2M	O
phase	O
without	O
affecting	O
cisplatin	O
-	O
induced	O
apoptosis	O
.	O

CONCLUSIONS	O
:	O

Our	O
results	O
suggest	O
that	O
,	O
in	O
ovarian	B-Cell
cancer	I-Cell
cells	I-Cell
,	O
Bcl	O
-	O
2	O
delays	O
cell	B-Cell
cycle	O
progression	O
by	O
promoting	O
accumulation	O
of	O
cells	B-Cell
in	O
S	O
phase	O
without	O
affecting	O
the	O
rate	O
of	O
apoptosis	O
.	O

Thus	O
,	O
in	O
addition	O
to	O
its	O
known	O
role	O
at	O
the	O
G0	O
/	O
G1	O
checkpoint	O
,	O
we	O
demonstrate	O
for	O
the	O
first	O
time	O
that	O
Bcl	O
-	O
2	O
also	O
regulates	O
the	O
S	O
phase	O
.	O

